Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Molife, Cliff
Haynes, Virginia S.
Nyhuis, Allen
Faries, Douglas E.
Gelwicks, Steve
Kelsey, Douglas K.
and
Alatorre, Carlos I.
2018.
Healthcare utilization and costs of children with attention deficit/hyperactivity disorder initiating atomoxetine versus extended-release guanfacine.
Current Medical Research and Opinion,
Vol. 34,
Issue. 4,
p.
619.
Stuhec, Matej
and
Locatelli, Igor
2018.
Attention deficit hyperactivity disorder pharmacotherapy in Slovenian adults: a population-based study.
International Journal of Clinical Pharmacy,
Vol. 40,
Issue. 2,
p.
341.
Golubchik, Pavel
and
Weizman, Abraham
2018.
The effect of methylphenidate treatment on suspiciousness in children with ADHD alone or comorbid with ODD.
International Journal of Psychiatry in Clinical Practice,
Vol. 22,
Issue. 2,
p.
109.
Stuhec, Matej
Lukić, Petar
and
Locatelli, Igor
2019.
Efficacy, Acceptability, and Tolerability of Lisdexamfetamine, Mixed Amphetamine Salts, Methylphenidate, and Modafinil in the Treatment of Attention-Deficit Hyperactivity Disorder in Adults: A Systematic Review and Meta-analysis.
Annals of Pharmacotherapy,
Vol. 53,
Issue. 2,
p.
121.
Piovani, Daniele
Clavenna, Antonio
and
Bonati, Maurizio
2019.
Prescription prevalence of psychotropic drugs in children and adolescents: an analysis of international data.
European Journal of Clinical Pharmacology,
Vol. 75,
Issue. 10,
p.
1333.
Wu, Chi-Shin
Shang, Chi-Yung
Lin, Hsiang-Yuan
and
Gau, Susan Shur-Fen
2021.
Differential Treatment Effects of Methylphenidate and Atomoxetine on Executive Functions in Children with Attention-Deficit/Hyperactivity Disorder.
Journal of Child and Adolescent Psychopharmacology,
Vol. 31,
Issue. 3,
p.
187.
Xu, Lu
Lv, Xiaozhen
Wang, Huali
Liu, Qingjing
Zhou, Shuzhe
Gao, Shuangqing
Yu, Xin
Deng, Siwei
Wang, Shengfeng
Chang, Zheng
and
Zhan, Siyan
2021.
Trends in Psychotropic Medication Prescriptions in Urban China From 2013 to 2017: National Population-Based Study.
Frontiers in Psychiatry,
Vol. 12,
Issue. ,
Dutta, Cintya Nirvana
Christov-Moore, Leonardo
Ombao, Hernando
and
Douglas, Pamela K.
2022.
Neuroprotection in late life attention-deficit/hyperactivity disorder: A review of pharmacotherapy and phenotype across the lifespan.
Frontiers in Human Neuroscience,
Vol. 16,
Issue. ,
Kaya, Şüheda
and
Kaya, Mehmet Kaan
2023.
OCT Findings in Patients with Methamphetamine Use Disorder.
Journal of Personalized Medicine,
Vol. 13,
Issue. 2,
p.
308.
Al-Dujaili, Zahraa
Hallit, Souheil
and
Al Faraj, Achraf
2023.
Knowledge, attitude, and readiness of pharmacists toward medication therapy management for patients with attention deficit hyperactivity disorder: a cross-sectional quantitative study.
International Journal of Clinical Pharmacy,
Vol. 45,
Issue. 5,
p.
1277.
Zain, Ekachaeryanti
Sugimoto, Atsunori
Egawa, Jun
and
Someya, Toshiyuki
2023.
Case report: Methylphenidate improved chronic pain in an adult patient with attention deficit hyperactivity disorder.
Frontiers in Psychiatry,
Vol. 14,
Issue. ,
Stuhec, Matej
Hahn, M.
Taskova, I.
Bayraktar, I.
Fitzgerald, I.
Molitschnig, L.
Tatarević, A.
Lindner, N.
Agnoletto, L.
and
da Costa, F. Alves
2023.
Clinical pharmacy services in mental health in Europe: a commentary paper of the European Society of Clinical Pharmacy Special Interest Group on Mental Health.
International Journal of Clinical Pharmacy,
Vol. 45,
Issue. 5,
p.
1286.
Skliarova, Tatiana
Pedersen, Henrik
Hafstad, Hege
Vaag, Jonas Rennemo
Lara-Cabrera, Mariela Loreto
and
Havnen, Audun
2023.
The construct validity of an abridged version of the general self-efficacy scale for adults with attention-deficit/hyperactivity disorder.
Frontiers in Psychiatry,
Vol. 14,
Issue. ,
Gémes, Katalin
Taipale, Heidi
Björkenstam, Emma
Rahman, Syed
Gustafsson, Klas
Tanskanen, Antti
Ekselius, Lisa
Mittendorfer-Rutz, Ellenor
and
Helgesson, Magnus
2023.
The role of sociodemographic and clinical factors in the initiation and discontinuation of attention deficit hyperactivity disorder medication among young adults in Sweden.
Frontiers in Psychiatry,
Vol. 14,
Issue. ,
Al Jaffal, Mohammed
Becker, David
Alhossein, Abdulkarim
Bakhiet, Salaheldin Farah
Aldabas, Rashed
Abaoud, Abdulrahman
Abdu Elrahim, Nagda Mohamed
and
Alharthi, Hanan
2024.
The psychometric properties of the ADHD rating scale—5 for children and adolescents, home version for Sudan.
Frontiers in Psychiatry,
Vol. 15,
Issue. ,
Li, Yanxi
and
Zhang, Lina
2024.
Efficacy of Cognitive Behavioral Therapy Combined with Pharmacotherapy Versus Pharmacotherapy Alone in Adult ADHD: A Systematic Review and Meta-Analysis.
Journal of Attention Disorders,
Vol. 28,
Issue. 3,
p.
279.
Comments
No Comments have been published for this article.